assays

It is available to researchers as they are able to use it in non-human assays, experiments and studies.

Second, you have the tech: microfluidic assays, and the idea of collecting them all in the same place.

They have refused to peer-review their protocols and validation data, so their assays are essentially a black box.

Development of interactive tools to allow for interpretation of results from genetic and genomic assays.

At the end of the day it's still chemists in labs preparing compounds that are then put through assays and clinical trials.

In all I'm very skeptical until they open up and provide peer-reviewed validation data for their assays.

It also fits into a long history of work out of the Mogil lab about the limitations in our current assays for pain.

The labels on food packages and the calorie counting websites get their numbers from nutritional assays, rather than in vivo measurements in actual humans.

There are certainly programs in big pharma to screen known drugs (that are already deemed safe for humans) in assays aimed at new targets.

I'd be concerned about the sensitivity of their assays from such a small sample volume (a drop of blood is about 20 microliters).

Multi variate index assays predicting irritable bowel disease.

A series of greenhouse competition assays in a variety of environ- ments would be a good start, and any identified differences could point to areas requiring further study.

From his current job's description (Clinical Genomics Database Web Developer) [1,2]: "The Clinical Genomics Database/Web Developer performs a variety of duties in the development of interactive websites, databases and interactive tools for the interpretation of genetic assays performed in a clinical setting.